IL-27, a heterodimeric cytokine composed of EB13 and p28 protein, induces proliferation of naive CD4+ T cells

被引:1163
作者
Pflanz, S [1 ]
Timans, JC [1 ]
Cheung, J [1 ]
Rosales, R [1 ]
Kanzler, H [1 ]
Gilbert, J [1 ]
Hibbert, L [1 ]
Churakova, T [1 ]
Travis, M [1 ]
Vaisberg, E [1 ]
Blumenschein, WM [1 ]
Mattson, JD [1 ]
Wagner, JL [1 ]
To, W [1 ]
Zurawski, S [1 ]
McClanahan, TK [1 ]
Gorman, DM [1 ]
Bazan, JF [1 ]
Malefyt, RD [1 ]
Rennick, D [1 ]
Kastelein, RA [1 ]
机构
[1] DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA
关键词
D O I
10.1016/S1074-7613(02)00324-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An efficient Th1-driven adaptive immune response requires activation of the T cell receptor and secretion of the T cell stimulatory cytokine IL-12 by activated antigen-presenting cells. IL-12 triggers Th1 polarization of naive CD4(+) T cells and secretion of IFN-gamma. We describe a new heterodimeric cytokine termed IL-27 that consists of EBI3, an IL-12p40-related protein, and p28, a newly discovered IL-12p35-related polypeptide. IL-27 is an early product of activated antigen-presenting cells and drives rapid clonal expansion of naive but not memory CD4+ T cells. It also strongly synergizes with IL-12 to trigger IFN-gamma production of naive CD4(+) T cells. IL-27 mediates its biologic effects through the orphan cytokine receptor WSX-1/TCCR.
引用
收藏
页码:779 / 790
页数:12
相关论文
共 31 条
  • [1] Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): Delivery to acute myeloid leukemic blasts using adeno-associated virus
    Anderson, R
    MacDonald, I
    Corbet, T
    Hacking, G
    Lowdell, MW
    Prentice, HG
    [J]. HUMAN GENE THERAPY, 1997, 8 (09) : 1125 - 1135
  • [2] HEMATOPOIETIC RECEPTORS AND HELICAL CYTOKINES
    BAZAN, JF
    [J]. IMMUNOLOGY TODAY, 1990, 11 (10): : 350 - 354
  • [3] Bolin LM, 1997, J NEUROSCI, V17, P5493
  • [4] Development of Th1-type immune responses requires the type I cytokine receptor TCCR
    Chen, Q
    Ghilardi, N
    Wang, H
    Baker, T
    Xie, MH
    Gurney, A
    Grewal, IS
    de Sauvage, FJ
    [J]. NATURE, 2000, 407 (6806) : 916 - 920
  • [5] David ZV, 1998, E EUR POLIT SOC, V12, P1
  • [6] A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes
    Devergne, O
    Hummel, M
    Koeppen, H
    LeBeau, MM
    Nathanson, EC
    Kieff, E
    Birkenbach, M
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (02) : 1143 - 1153
  • [7] Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin
    Devergne, O
    Birkenbach, M
    Kieff, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) : 12041 - 12046
  • [8] Expression of Epstein-Barrvirus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy -: Involvement of syncytiotrophoblasts and extravillous trophoblasts
    Devergne, O
    Coulomb-L'Herminé, A
    Capel, F
    Moussa, M
    Capron, F
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2001, 159 (05) : 1763 - 1776
  • [9] CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
    Elson, GCA
    Lelièvre, E
    Guillet, C
    Chevalier, S
    Plun-Favreau, H
    Froger, J
    Suard, I
    de Coignac, AB
    Delneste, Y
    Bonnefoy, JY
    Gauchat, JF
    Gascan, H
    [J]. NATURE NEUROSCIENCE, 2000, 3 (09) : 867 - 872
  • [10] FISCHER M, 1997, NAT BIOTECHNOL, V69, P139